MetaCap

Allarity Therapeutics (ALLR) vs Lipocine (LPCN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Lipocine (LPCN) has outperformed Allarity Therapeutics (ALLR) over the past year, losing 38.9% versus a loss of 43.8%. Lipocine is the larger company by market cap ($15.9 million vs $15.6 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALLR-43.77%LPCN-31.68%
+265%+98%-69%
Oct 7, 20251 yearOct 7, 2026
ALLR-100.00%LPCN-87.79%
+83%-13%-109%
Dec 20, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALLR versus LPCN key metrics
MetricALLRLPCN
Share price$0.9819$1.93
Market cap$15.62M$15.91M
1-day change-0.21%-12.27%
YTD return-8.89%-75.97%
1-year return-43.77%-38.92%
5-year return—-88.55%
EPS (TTM)$-0.79$-1.85
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$1.84$12.37
52-week low$0.769$1.81
Distance from 52-week high-46.64%-84.40%
Average volume90.63K1.68M
Shares outstanding15.91M8.24M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

ALLR vs LPCN FAQ

Which is bigger, Allarity Therapeutics or Lipocine?

Lipocine (LPCN) is larger, with a market capitalization of $15.91M compared with $15.62M for Allarity Therapeutics (ALLR).

Which stock has performed better over the past year, ALLR or LPCN?

LPCN returned -38.92% over the past 12 months, compared with -43.77% for ALLR (price return, excluding dividends). Past performance does not predict future results.

Are Allarity Therapeutics and Lipocine in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons